Blog

Avation PLC (LSE:AVAP) has marked its twentieth anniversary by reporting a fully leased aircraft fleet, an expanded orderbook for ATR turboprops and continued progress in strengthening its balance sheet.

The Singapore-based aircraft leasing company said strong passenger demand across the Asia-Pacific region and limited availability of new aircraft have continued to support lease rates and aircraft values.

Fleet Fully Deployed as Lease Revenue Builds

Avation’s portfolio currently comprises 33 aircraft leased to 17 airlines operating across 17 countries, including a mix of narrowbody jets, ATR turboprops and a widebody aircraft.

With every aircraft on lease, the company has accumulated approximately US$321 million of contracted lease revenue yet to be recognised, providing strong visibility over future earnings.

The remaining average lease term across the portfolio stands at approximately 4.1 years, supporting predictable long-term cash flows.

ATR Orderbook Expanded

The company has increased its commitment to the regional aviation market by converting existing purchase rights into firm orders for 13 ATR 72-600 aircraft scheduled for delivery through 2029.

Avation also retains purchase rights over a further 19 ATR aircraft extending to 2034, giving the company flexibility to expand its fleet while benefiting from previously agreed pricing.

Management believes the enlarged orderbook positions the business to capitalise on continued demand for regional turboprop aircraft and said it is also evaluating selective acquisitions of narrowbody aircraft in the secondary market.

Continued Fleet Growth and Balance Sheet Improvement

Since June 2025, Avation has delivered and placed two new ATR 72-600 aircraft with airlines in South Korea and Cambodia.

The company has also successfully transitioned seven ATR 72-600 aircraft to five airline customers, including Finnair, and expects to deliver a further three aircraft before the end of 2026.

Financially, Avation continued to reduce leverage by repaying US$130 million of secured debt and increasing the number of unencumbered aircraft in its portfolio to 10.

The company also refinanced its unsecured debt through the issuance of US$300 million of Senior 8.5% Notes due in 2031.

As of mid-July 2026, Avation held approximately US$105 million in unaudited cash balances and has repurchased more than eight million ordinary shares since June 2025 under its ongoing share buyback programme.

Financial Risks Remain

Although the company has made progress in strengthening its balance sheet, Avation continues to operate with relatively high leverage and remains affected by negative profitability.

Technical indicators also remain weak, suggesting cautious near-term market sentiment despite positive operational developments and continued capital management initiatives.

About Avation PLC

Avation PLC is a Singapore-based commercial aircraft leasing company that owns and manages a fleet of passenger aircraft leased to airlines around the world.

Its portfolio includes narrowbody jets, ATR turboprops and a widebody aircraft, with a particular strategic focus on regional aviation in the Asia-Pacific market.

Over the past two decades, the company has built long-term relationships with airlines across multiple regions while expanding its fleet through disciplined acquisitions, active asset management and a combination of secured and unsecured financing.

Brave Bison Group plc (LSE:BBSN) has confirmed it is in discussions regarding a possible acquisition of System1 Group plc, with the proposed transaction aimed at creating what the company describes as AIM’s challenger marketing data and technology business.

The proposal would see Brave Bison acquire the remaining 72% of System1 that it does not already own through a combination of cash and newly issued shares.

Proposed Offer Values System1 at £43.1 Million

Under the indicative terms, System1 shareholders would receive 68 pence in cash together with 2.7553 new Brave Bison shares for each System1 share held.

The proposal values System1 at approximately £43.1 million and represents a premium of around 65% to the company’s undisturbed share price.

If completed, System1 shareholders would own roughly 19% of the enlarged business, while Brave Bison said no additional equity fundraising would be required to complete the transaction.

Combined Business Targets Greater Scale

The enlarged group would generate pro forma net revenue of approximately £79 million and adjusted EBITDA of around £14 million, according to the companies.

Brave Bison intends to organise the combined business into three AI-enabled marketing divisions covering marketing effectiveness, marketing skills and training, and full-funnel digital marketing services.

Management believes the transaction could deliver operational cost synergies while creating a more diversified business with a higher-margin revenue mix.

The larger group is also expected to benefit from improved share liquidity and could become eligible for inclusion in the AIM 100 Index, potentially increasing its appeal to institutional investors.

Financial Recovery Supports Growth Strategy

Brave Bison has strengthened its financial performance following a turnaround in recent years, supported by strong revenue growth during 2025 and a relatively low level of debt.

Technical indicators also remain favourable, reflecting positive share price momentum.

However, the company’s valuation remains relatively demanding, while fluctuations in profitability and cash generation continue to present risks as management pursues further expansion.

About Brave Bison

Brave Bison Group plc is a digital marketing and technology company providing services across performance marketing, social media, influencer marketing and data-driven customer insights.

The business focuses on AI-enabled marketing solutions for enterprise customers across the UK, Europe and the United States and plans to structure its operations around marketing effectiveness, professional training and end-to-end digital marketing services.

Grafton Group (LSE:GFTU) has delivered higher first-half revenue and reaffirmed its full-year profit guidance, with acquisitions and strong performances in Ireland and Iberia helping to offset weaker trading conditions in Great Britain and Northern Europe.

The building materials distributor also announced a new share buyback programme, continuing its strategy of returning excess capital to shareholders.

Acquisitions and Regional Growth Support Revenue

Group revenue increased 6.7% to £1.34 billion during the first half of the year, benefiting from recent acquisitions in Ireland and Spain as well as continued strong trading across Iberia and the Island of Ireland.

On a like-for-like basis, average daily revenue rose 0.6%, with improving demand in Ireland and solid growth in Iberia balancing more challenging market conditions in Great Britain and softer activity across Northern Europe.

Company Reaffirms Full-Year Profit Outlook

Grafton maintained its guidance for adjusted operating profit of between £190 million and £200 million for the 2026 financial year.

Management expects trading conditions in the second half to remain broadly consistent with those seen during the opening six months, with ongoing resilience in Ireland and Iberia expected to offset continued weakness in the UK market.

The company also noted that it does not anticipate a significant recovery in Great Britain in the near term.

Share Buyback Continues Capital Return Strategy

Alongside its trading update, Grafton announced a new share repurchase programme of up to £25 million.

Including the latest initiative, the group will have returned approximately £457.6 million to shareholders since 2022, reducing its issued share capital by almost 22%.

Management said the buyback reflects its disciplined approach to capital allocation, balancing shareholder returns with targeted investment opportunities that support long-term growth.

Strong Financial Position Offsets Market Headwinds

Grafton continues to benefit from healthy cash generation and a conservative balance sheet, supporting both investment and shareholder distributions.

The shares also offer a moderate valuation alongside a dividend yield of around 4%.

However, technical indicators remain relatively weak, with the share price trading below key moving averages, while management continues to highlight cost inflation and subdued demand in several regions as near-term challenges.

About Grafton Group

Grafton Group plc is a leading European distributor of construction products and building materials, operating across the Island of Ireland, Great Britain, Northern Europe and Iberia.

The company trades through around 470 branches and employs approximately 10,000 people. Its portfolio includes well-known brands such as Chadwicks, Woodie’s and MacBlair in Ireland, together with Selco, Leyland SDM, T.G. Lynes, CPI EuroMix and StairBox in Great Britain.

Through its combination of trade distribution and consumer-facing home improvement businesses, Grafton has established a diversified platform serving both professional customers and retail markets across Europe.

80 Mile PLC (LSE:80M) has commenced drilling at its Disko-Nuussuaq project in West Greenland, marking the next stage of exploration at a prospect the company believes has the potential to host a large nickel-copper-cobalt-platinum group metals discovery.

The work forms part of a broader strategy to build a diversified portfolio spanning critical minerals, hydrocarbons and low-carbon energy assets across Greenland and Italy.

Drilling Targets Large Sulphide Deposits

The company confirmed that drilling operations are now underway, with rigs fully commissioned, cementing completed and pressure testing successfully carried out ahead of deeper exploration.

The initial drill holes are expected to reach depths of up to 1,000 metres as 80 Mile tests a series of large magmatic massive sulphide targets across the project.

Previous exploration has produced encouraging results, including the discovery of a 28-tonne massive sulphide boulder and high-grade surface samples, supporting the company’s view that Disko-Nuussuaq could host a Norilsk-style nickel-copper mineral system.

A US$30 million joint venture funding package is expected to finance the current exploration campaign, helping to accelerate drilling, resource definition and project development while strengthening 80 Mile’s exposure to the growing battery metals sector.

Strategic Location Supports Development

Covering more than 3,000 square kilometres, the Disko-Nuussuaq project is located in a geological setting considered comparable to Russia’s Norilsk mining district, one of the world’s largest sources of nickel and copper.

The project also benefits from established infrastructure near Ilulissat, where the company operates a logistics base to support exploration activities.

Management believes the combination of large-scale exploration targets, existing infrastructure and third-party funding provides a strong platform for advancing the project if drilling confirms a significant mineral discovery.

Diversified Portfolio Continues to Expand

Beyond Disko-Nuussuaq, 80 Mile maintains a broad portfolio of energy and mining assets.

The company retains a 30% interest in the Jameson gas and liquids project in East Greenland following a farm-out agreement that provides fully funded deep exploration drilling during 2026.

Its portfolio also includes the Dundas ilmenite project in Greenland, which has a JORC-compliant mineral resource and the necessary development permits, as well as the Greenswitch Ferrandina biofuels and sustainable aviation fuel facility in Italy.

Together, these assets provide exposure to both traditional energy resources and materials supporting the global energy transition.

Financial Position Reflects Development Stage

Like many exploration companies, 80 Mile continues to operate without revenue while investing heavily in advancing its portfolio, resulting in ongoing losses and negative operating and free cash flow.

The company maintains relatively low leverage, while technical indicators have improved in recent months, with the shares trading above key short-term moving averages and broader momentum remaining positive.

However, valuation continues to be constrained by the absence of earnings and dividend payments.

About 80 Mile PLC

80 Mile PLC is an exploration and development company listed on AIM, the Frankfurt Stock Exchange and the U.S. OTC market.

The company is focused on developing critical minerals and hydrocarbon projects in Greenland alongside industrial gas and sustainable fuels assets in Italy.

Its principal assets include the Disko-Nuussuaq nickel-copper-cobalt-platinum group metals project, the Jameson gas and liquids project, the Dundas ilmenite project and the Greenswitch Ferrandina biofuels and sustainable aviation fuel facility.

IXICO plc (LSE:IXI) has maintained its upgraded revenue guidance for 2026 and 2027 despite the cancellation of two Huntington’s disease clinical programmes that it was supporting.

The neuroscience imaging specialist said the impact on its order book has been offset by strong contract wins secured earlier in the year, allowing management to remain confident in the company’s financial outlook.

Order Book Remains Strong Following New Contract Wins

IXICO expects the discontinued Huntington’s disease studies to reduce its contracted order book by approximately £1.5 million over the next two financial years.

However, the company noted that it secured around £8.0 million of new Huntington’s disease-related contract awards during the first half of FY2026.

As a result, IXICO’s overall order book remains 21% higher than it was at the end of FY2025, providing continued revenue visibility and supporting the board’s decision to leave its upgraded guidance unchanged.

Management also continues to expect the business to meet or exceed current market forecasts.

AI Imaging Platform Supports Neurology Research

IXICO operates as an Imaging Contract Research Organisation, providing artificial intelligence-driven imaging analysis and biomarker services for neurological disease research.

Its proprietary IXI platform processes imaging data from clinical trials conducted around the world, helping researchers measure disease biomarkers and assess treatment effectiveness across conditions including Alzheimer’s disease, Huntington’s disease and Parkinson’s disease.

The company’s imaging specialists combine advanced analytics with clinical expertise to generate insights that support pharmaceutical companies and research organisations developing new neurological therapies.

Commercial Progress Offsets Financial Challenges

While IXICO continues to report operating losses and negative operating cash flow, management highlighted strong commercial momentum and improving operational leverage following recent contract wins.

The company also noted that a strengthened cash position following its recent capital raising provides additional financial flexibility.

Technical indicators remain supportive, although shares have moved into territory that some investors may view as overbought. Valuation also continues to be affected by the absence of profitability and a dividend.

About IXICO plc

IXICO plc is a specialist neuroscience imaging and biomarker analytics company that provides end-to-end imaging services for clinical trials in neurological diseases.

Using its AI-powered IXI platform, the company supports pharmaceutical companies, biotechnology firms, research consortia and non-profit organisations conducting studies in Alzheimer’s disease, Huntington’s disease, Parkinson’s disease and other neurological conditions.

With more than two decades of experience, IXICO has analysed hundreds of thousands of medical images and developed a global network of specialist imaging centres, helping improve the consistency and reliability of clinical trial data.

Sabien Technology Group (LSE:SNT) has reported a stronger order book and an improved financial position as it continues to reshape the business through a wider strategic review.

Although revenue eased slightly during the 2026 financial year amid challenging market conditions, management said the company has entered the new financial year with improved sales visibility and a stronger platform for future growth.

Order Book Provides Improved Revenue Visibility

Sabien generated customer orders of more than £908,000 during FY2026 and expects to report revenue exceeding £746,000.

The slight decline in revenue compared with the previous year reflected a cautious capital spending environment, with some customer installations moving into the current financial year.

As a result, the company has started FY2027 with an opening order book of more than £196,000, providing greater confidence in near-term revenue generation.

Strategic Initiatives Continue

Management said the company’s balance sheet has strengthened following the repayment of outstanding loans, creating additional financial flexibility.

At the same time, Sabien continues to evaluate investment opportunities and strategic partnerships that could accelerate the commercial rollout of its M2G energy efficiency platform.

The board is also reviewing its interests related to COF while maintaining flexibility to pursue opportunities that support higher-margin growth and improve operational performance.

Focus on Scalable Growth

Executive Chairman Richard Parris said the business is in a stronger position than it was a year ago, with a clearer strategic direction and a disciplined approach to capital allocation.

Key priorities include expanding distribution channels, completing the migration of the M2G platform to the EVO architecture and improving cash generation to support sustainable long-term growth in the energy efficiency market.

Financial Performance Still Under Pressure

Despite operational progress, Sabien continues to face financial challenges, including ongoing losses, negative shareholders’ equity and negative operating and free cash flow.

Technical indicators also remain weak, with the shares trading in a sustained downtrend and broader market momentum remaining negative.

Valuation support remains limited while the company is loss-making and does not currently pay a dividend.

About Sabien Technology Group

Sabien Technology Group plc is a London-listed developer of energy efficiency technologies for commercial buildings.

Its M2G intelligent boiler optimisation platform and cloud-based energy management solutions are designed to reduce gas consumption, lower carbon emissions and improve the operational performance of heating systems, with the majority of the company’s revenue generated from products serving the green economy.

Aptamer Group (LSE:APTA) expects to report higher revenue for the 2026 financial year, supported by continued demand for its fee-for-service activities and the first licensing income generated from commercial agreements.

The life sciences company also recorded significant growth in its sales pipeline, providing improved visibility over future revenue as it expands adoption of its Optimer technology platform.

Licensing Income Supports Revenue Increase

The company expects FY2026 revenue of approximately £1.5 million, representing a 25% increase from the previous year.

Growth was driven by a combination of contract research work and initial licensing revenue from partnerships with Twist Bioscience and Alphazyme, marking an important step in Aptamer’s strategy to increase higher-margin recurring income.

The commercial pipeline expanded by 55% to £4.8 million during the year, while the FY2027 order book reached approximately £0.6 million, reflecting growing customer interest in the company’s Optimer platform.

Partnerships and Platform Investment Continue

Aptamer continued to strengthen its commercial relationships during the year, advancing projects with several leading global pharmaceutical companies alongside programmes spanning diagnostics, food testing and radiopharmaceutical development.

The company also continued investing in artificial intelligence-enabled discovery tools and greater automation across its technology platform to improve efficiency and accelerate product development.

Management believes licensing will become an increasingly important contributor to future earnings as additional commercial agreements are secured.

Funding Extends Cash Runway

Following a fundraising completed in April 2026, Aptamer said it has sufficient funding to support operations until at least 2028.

The strengthened financial position allows the company to continue investing in product development, commercial expansion and platform enhancements while pursuing additional licensing opportunities during FY2027.

Financial Challenges Remain

Despite improving commercial momentum, Aptamer continues to operate at a loss and remains affected by negative cash flow.

Technical indicators also remain weak, with the shares trading below key moving averages and broader market momentum remaining negative, although oversold conditions provide some support.

Valuation also continues to be constrained by negative earnings and the absence of a dividend.

About Aptamer Group Plc

Aptamer Group Plc is a life sciences company developing synthetic Optimer binders for use in diagnostics, therapeutics and research applications.

The company works with pharmaceutical and biotechnology partners to integrate its platform into diagnostic assays, enzyme technologies and emerging therapeutic programmes, while expanding its focus on higher-value licensing opportunities and proprietary asset development.